Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

A Proportional Hazards Model for the Subdistribution of a Competing Risk

Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290

Human mesenchymal stem cells modulate allogeneic immune cell responses

Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511

Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production

Németh, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364

Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities

Galipeau, J., & Sensébé, L. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.05.004 · Cited by 1,819

Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting

Wiklander, O. P. B., Nordin, J. Z., O'Loughlin, A., Gustafsson, Y., Corso, G., Mäger, I., Vader, P., Lee, Y., Sork, H., Seow, Y., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.26316 · Cited by 1,730

The MSC: An Injury Drugstore

Caplan, A. I., & Correa, D. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.06.008 · Cited by 1,682

Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications

Wang, Y., Chen, X., Cao, W., & Shi, Y. (2014) · Nature Immunology · doi:10.1038/ni.3002 · Cited by 1,452

Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper

Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F. A., del Portillo, H. A., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.30087 · Cited by 1,491

Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases

Shi, Y., Wang, Y., Li, Q., Liu, K., Hou, J., Shao, C., & Wang, Y. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0023-5 · Cited by 1,223

Stem Cell Paracrine Actions and Tissue Regeneration

Baraniak, P. R., & McDevitt, T. C. (2010) · Regenerative Medicine · doi:10.2217/rme.09.74 · Cited by 843

Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion

Eggenhofer, E., Benseler, V., Kroemer, A., Popp, F. C., Geissler, E. K., Schlitt, H. J., Baan, C. C., Dahlke, M. H., & Hoogduijn, M. J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00297 · Cited by 804

Mesenchymal stromal cells: new directions

Keating, A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.015 · Cited by 778

Mesenchymal stem cell–educated macrophages: A novel type of alternatively activated macrophages

Kim, J., & Hematti, P. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.09.004 · Cited by 785

Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery

Yeo, R. W. Y., Lai, R. C., Zhang, B., Tan, S. S., Yin, Y., Teh, B. J., & Lim, S. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.001 · Cited by 746

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

Duijvestein, M., Vos, A. C. W., Roelofs, H., Wildenberg, M. E., Wendrich, B. B., Verspaget, H. W., Kooy-Winkelaar, E. M. C., Koning, F., Zwaginga, J. J., Fidder, H. H., et al. (2010) · Gut · doi:10.1136/gut.2010.215152 · Cited by 622

Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression

Ren, G., Su, J., Zhang, L., Zhao, X., Ling, W., L'huillie, A., Zhang, J., Lu, Y., Roberts, A. I., Ji, W., et al. (2009) · Stem Cells · doi:10.1002/stem.118 · Cited by 597

Repair of Tissues by Adult Stem/Progenitor Cells (MSCs): Controversies, Myths, and Changing Paradigms

Prockop, D. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.62 · Cited by 577

Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair

Shi, Y., Hu, G., Su, J., Li, W., Chen, Q., Shou, P., Xu, C., Chen, X., Huang, Y., Zhu, Z., et al. (2010) · Cell Research · doi:10.1038/cr.2010.44 · Cited by 575

Exosomes for drug delivery—A novel application for the mesenchymal stem cell

Lai, R. C., Yeo, R. W. Y., Tan, K. H., & Lim, S. K. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.08.008 · Cited by 546

Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells

de Witte, S. F. H., Luk, F., Sierra Parraga, J. M., Gargesha, M., Merino, A., Korevaar, S. S., Shankar, A. S., O'Flynn, L., Elliman, S. J., Roy, D., et al. (2018) · Stem Cells · doi:10.1002/stem.2779 · Cited by 504

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

Ghannam, S., Bouffi, C., Djouad, F., Jorgensen, C., & Noël, D. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt2 · Cited by 507

Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells

Siegel, G., Kluba, T., Hermanutz-Klein, U., Bieback, K., Northoff, H., & Schäfer, R. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-146 · Cited by 493

Mesenchymal Stem Cell: Keystone of the Hematopoietic Stem Cell Niche and a Stepping-Stone for Regenerative Medicine

Frenette, P. S., Pinho, S., Lucas, D., & Scheiermann, C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095919 · Cited by 462

Adipose Tissue-Derived Multipotent Stromal Cells Have a Higher Immunomodulatory Capacity Than Their Bone Marrow-Derived Counterparts

Melief, S. M., Zwaginga, J. J., Fibbe, W. E., & Roelofs, H. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0184 · Cited by 442

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

Tarte, K., Gaillard, J., Lataillade, J.-J., Fouillard, L., Becker, M., Mossafa, H., Tchirkov, A., Rouard, H., Henry, C., Splingard, M., et al. (2010) · Blood · doi:10.1182/blood-2009-05-219907 · Cited by 430

Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

François, M., Copland, I. B., Yuan, S., Romieu-Mourez, R., Waller, E. K., & Galipeau, J. (2012) · Cytotherapy · doi:10.3109/14653249.2011.623691 · Cited by 375

Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients

Zhang, Z., Lin, H., Shi, M., Xu, R., Fu, J., Lv, J., Chen, L., Lv, S., Li, Y., Yu, S., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07024.x · Cited by 372

Ex vivo gene transfer and correction for cell-based therapies

Naldini, L. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2985 · Cited by 358

Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects

Marquez-Curtis, L. A., Janowska-Wieczorek, A., McGann, L. E., & Elliott, J. A. W. (2015) · Cryobiology · doi:10.1016/j.cryobiol.2015.07.003 · Cited by 346

Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells

Holzwarth, C., Vaegler, M., Gieseke, F., Pfister, S. M., Handgretinger, R., Kerst, G., & Müller, I. (2010) · BMC Cell Biology · doi:10.1186/1471-2121-11-11 · Cited by 314

The Immunomodulatory Functions of Mesenchymal Stromal/Stem Cells Mediated via Paracrine Activity

Zhou, Y., Yamamoto, Y., Xiao, Z., & Ochiya, T. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071025 · Cited by 303

Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER)

Glassberg, M. K., Minkiewicz, J., Toonkel, R. L., Simonet, E. S., Rubio, G. A., DiFede, D., Shafazand, S., Khan, A., Pujol, M. V., LaRussa, V. F., et al. (2017) · Chest · doi:10.1016/j.chest.2016.10.061 · Cited by 249

The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy

Hoogduijn, M. J., Popp, F., Verbeek, R., Masoodi, M., Nicolaou, A., Baan, C., & Dahlke, M.-H. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.06.019 · Cited by 248

Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo

Lanza, C., Morando, S., Voci, A., Canesi, L., Principato, M. C., Serpero, L. D., Mancardi, G., Uccelli, A., & Vergani, L. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06268.x · Cited by 175

Mesenchymal stem cell-educated macrophages

Eggenhofer, E., & Hoogduijn, M. J. (2012) · Transplantation Research · doi:10.1186/2047-1440-1-12 · Cited by 169

Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice

Meier, R. P. H., Mahou, R., Morel, P., Meyer, J., Montanari, E., Muller, Y. D., Christofilopoulos, P., Wandrey, C., Gonelle-Gispert, C., & Bühler, L. H. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.030 · Cited by 153

Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge

Brandau, S., Jakob, M., Hemeda, H., Bruderek, K., Janeschik, S., Bootz, F., & Lang, S. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0410207 · Cited by 155

Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial

Shi, M., Li, Y.-Y., Xu, R.-N., Meng, F.-P., Yu, S.-J., Fu, J.-L., Hu, J.-H., Li, J.-X., Wang, L.-F., Jin, L., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10199-2 · Cited by 151

Effects of Hypoxia on the Immunomodulatory Properties of Adipose Tissue-Derived Mesenchymal Stem cells

Roemeling-van Rhijn, M., Mensah, F. K. F., Korevaar, S. S., Leijs, M. J., van Osch, G. J. V. M., IJzermans, J. N. M., Betjes, M. G. H., Baan, C. C., Weimar, W., & Hoogduijn, M. J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00203 · Cited by 150

Genetic Engineering of Mesenchymal Stem Cells and Its Application in Human Disease Therapy

Hodgkinson, C. P., Gomez, J. A., Mirotsou, M., & Dzau, V. J. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.165 · Cited by 150

The extracellular vesicles‐derived from mesenchymal stromal cells: A new therapeutic option in regenerative medicine

Nooshabadi, V. T., Mardpour, S., Yousefi‐Ahmadipour, A., Allahverdi, A., Izadpanah, M., Daneshimehr, F., Ai, J., Banafshe, H. R., & Ebrahimi‐Barough, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26726 · Cited by 133

The issue of heterogeneity of MSC-based advanced therapy medicinal products–a review

Česnik, A. B., & Švajger, U. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1400347 · Cited by 128

Mesenchymal stem cell transplantation in multiple sclerosis

Cohen, J. A. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.12.009 · Cited by 127

Mesenchymal stem cells: mechanisms and role in bone regeneration

Qin, Y., Guan, J., & Zhang, C. (2014) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2013-132387 · Cited by 122

Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey

Kuci, Z., Bonig, H., Kreyenberg, H., Bunos, M., Jauch, A., Janssen, J. W. G., kifi, M., Michel, K., Eising, B., Lucchini, G., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.140368 · Cited by 118

Stem cells as vectors for antitumour therapy

Loebinger, M. R., & Janes, S. M. (2010) · Thorax · doi:10.1136/thx.2009.128025 · Cited by 109

Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model

Honoki, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1220 · Cited by 90

Allogeneic Bone Marrow Mesenchymal Stem Cell Transplantation in Patients with UDCA-Resistant Primary Biliary Cirrhosis

Wang, L., Han, Q., Chen, H., Wang, K., Shan, G.-L., Kong, F., Yang, Y.-J., Li, Y.-Z., Zhang, X., Dong, F., et al. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0500 · Cited by 89

Human Adipose-Derived Mesenchymal Stem Cells in Cell Therapy: Safety and Feasibility in Different "Hospital Exemption" Clinical Applications

Vériter, S., André, W., Aouassar, N., Poirel, H. A., Lafosse, A., Docquier, P.-L., & Dufrane, D. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139566 · Cited by 78

Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells

Norozi, F., Ahmadzadeh, A., Shahrabi, S., Vosoughi, T., & Saki, N. (2016) · Tumor Biology · doi:10.1007/s13277-016-5187-7 · Cited by 69

Human Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative

Stroncek, D. F., Jin, P., McKenna, D. H., Takanashi, M., Fontaine, M. J., Pati, S., Schäfer, R., Peterson, E., Benedetti, E., & Reems, J.-A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00458 · Cited by 59

Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stress

Laing, A. G., Fanelli, G., Ramirez-Valdez, A., Lechler, R. I., Lombardi, G., & Sharpe, P. T. (2019) · PLOS ONE · doi:10.1371/journal.pone.0213170 · Cited by 59

Progress and emerging techniques for biomaterial-based derivation of mesenchymal stem cells (MSCs) from pluripotent stem cells (PSCs)

Prakash, N., Kim, J., Jeon, J., Kim, S., Arai, Y., Bello, A. B., Park, H., & Lee, S.-H. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00371-0 · Cited by 56

Mesenchymal stem cells contribute to tumor cell proliferation by direct cell-cell contact interactions

Roorda, B. D., Elst, A. T., Boer, T. G. J. M.-D., Kamps, W. A., & de Bont, E. S. J. M. (2010) · Cancer Investigation · doi:10.3109/07357900903179625 · Cited by 51

ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cells

Blanc, K. L., Dazzi, F., English, K., Farge, D., Galipeau, J., Horwitz, E. M., Kadri, N., Krampera, M., Lalu, M. M., Nolta, J., et al. (2025) · Cytotherapy · doi:10.1016/j.jcyt.2025.01.005 · Cited by 48

Mesenchymal stem/stromal cells enhance engraftment, vasculogenic and pro-angiogenic activities of endothelial colony forming cells in immunocompetent hosts

Shafiee, A., Patel, J., Lee, J. S., Hutmacher, D. W., Fisk, N. M., & Khosrotehrani, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-13971-3 · Cited by 46

Umbilical cord tissue–derived mesenchymal stromal cells maintain immunomodulatory and angiogenic potencies after cryopreservation and subsequent thawing

Bárcia, R. N., Santos, J. M., Teixeira, M., Filipe, M., Pereira, A. R. S., Ministro, A., Água-Doce, A., Carvalheiro, M., Gaspar, M. M., Miranda, J. P., et al. (2017) · Cytotherapy · doi:10.1016/j.jcyt.2016.11.008 · Cited by 40

Advantages of pooling of human bone marrow-derived mesenchymal stromal cells from different donors versus single-donor MSCs

Kannan, S., Gokul Krishna, S., Gupta, P. K., & Kolkundkar, U. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-62544-8 · Cited by 39

Mesenchymal stem cell derived extracellular vesicles: Promising immunomodulators against autoimmune, autoinflammatory disorders and SARS-CoV-2 infection

BULUT, Ö., & GÜRSEL, İ. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2002-79 · Cited by 34

Adoptive Transfer of Treg Cells Combined with Mesenchymal Stem Cells Facilitates Repopulation of Endogenous Treg Cells in a Murine Acute GVHD Model

Lee, E.-S., Lim, J.-Y., Im, K.-I., Kim, N., Nam, Y.-S., Jeon, Y.-W., & Cho, S.-G. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138846 · Cited by 34

Hematopoietic and Mesenchymal Stem Cells for the Treatment of Chronic Respiratory Diseases: Role of Plasticity and Heterogeneity

Conese, M., Piro, D., Carbone, A., Castellani, S., & Di Gioia, S. (2014) · The Scientific World Journal · doi:10.1155/2014/859817 · Cited by 28

In vitro simulation of the early proinflammatory phase in fracture healing reveals strong immunomodulatory effects of CD146‐positive mesenchymal stromal cells

Herrmann, M., Stanić, B., Hildebrand, M., Alini, M., & Verrier, S. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2902 · Cited by 23

TWIST1 and TSG6 are coordinately regulated and function as potency biomarkers in human MSCs

Lee, R. H., Boregowda, S. V., Shigemoto-Kuroda, T., Bae, E., Haga, C. L., Abbery, C. A., Bayless, K. J., Haskell, A., Gregory, C. A., Ortiz, L. A., et al. (2023) · Science Advances · doi:10.1126/sciadv.adi2387 · Cited by 16

Cryopreservation of mesenchymal stem/stromal cells using a DMSO-free solution is comparable to DMSO-containing cryoprotectants: results of an international multicenter PACT/BEST collaborative study

Mamo, T., Cox, C. A., Demorest, C., Fontaine, M. J., Hubel, A., Kelley, L., Khan, A., Marks, D. C., Pati, S., Reems, J.-A., et al. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2024.07.001 · Cited by 16